Results 41 to 50 of about 86,753 (203)
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Proliferation and survival of Hodgkin and Reed/Sternberg (HRS) cells, the malignant cells of classical Hodgkin lymphoma (cHL), are dependent on constitutive activation of nuclear factor {kappa}B (NF-{kappa}B).
Inga Vater +25 more
core +1 more source
Epstein-Barr Virus Promotes Tumorigenicity and Worsens Hodgkin Lymphoma Prognosis by Activating JAK/STAT and NF-κB Signaling Pathways [PDF]
Background: Epstein-Barr virus (EBV) is detected in 40% of patients with Hodgkin lymphoma (HL). During latency, EBV induces epigenetic alterations to the host genome and decreases the expression of pro-apoptotic proteins.
Mohamed Ali Alabiad +11 more
doaj +1 more source
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma
Background: Hodkin s lymphoma is one of the most frequent lymphoma in western world. Despite an overall good prognosis some patients suffer relapsing tumors which are difficult to cure.
Renné Christoph +5 more
core +1 more source
Hodgkin transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma [PDF]
Introduction. In rare cases, chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma may transform into Hodgkin lymphoma, with about a hundred cases reported in the literature so far.
Vučić Miodrag +3 more
doaj +1 more source
Alterations of Spermatozoa Proteomic Profile in Men with Hodgkin’s Disease Prior to Cancer Therapy
Purpose: Hodgkin’s disease (HD) is a type of cancer affecting men in the reproductive age with potential consequences on their fertility status. This study aims to analyze sperm parameters, alterations in proteomic profiles and validate selected protein
Ana D. Martins +5 more
doaj +1 more source
This synthesis of the literature on radiotherapy for Hodgkin's Disease is based on 104 scientific articles, including 2 meta-analyses, 22 randomized studies, 5 prospective studies, and 58 retrospective studies. These studies involve 38,362 patients.
openaire +2 more sources
Radiotherapy plays an important role in the treatment of early‐stage Hodgkin lymphoma, but late toxicities such as cardiovascular disease and second malignancy are a major concern.
Jonathan M. Tomaszewski +4 more
doaj +1 more source
Thrombotic thrombocytopenic purpura associated with Hodgkin lymphoma and non-Hodgkin lymphoma
Sir, Thrombotic thrombocytopenic purpura (TTP) is a rare haematological disease characterised by thrombotic microangiopathy in the setting of diminished ADAMTS13 enzyme activity.
Yaxley, Julian, Tomlinson, Ross
core +1 more source
Modern Pharmacological Approach to the Treatment of Hodgkin Lymphoma
The initial treatment for patients with Hodgkin lymphoma is based on the histologic characteristics of the disease, the stage at presentation, and the presence or absence of prognostic factors associated with poor outcome.
Ohfuji, Arisa
core
Background: Hodgkin lymphoma (HL) is a malignant process involving the lympho-reticular system that accounts for 6% of childhood cancers. Infectious agents may be involved, such as human herpes virus 6, cytomegalovirus, and Epstein-Barr virus ...
Sawsan Abbas, Ruaa Ali
doaj +1 more source

